Sukhtian Faisal Ghiath
Insider CIK 1716033 · OTLK Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 95,398 | $1.05 | $100.2K | 220,972 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 95,398 | $1.05 | $100.0K | 220,972 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-05-27 | 2026-05-27 | 122,174 | $0.41 | $50.1K | 125,574 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-03 | 2025-10-03 | 117,296 | — | $0 | 117,296 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 286,734 | — | $0 | 286,734 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 12,323 | — | $0 | 12,323 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 19,771 | — | $0 | 19,771 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 56,636 | — | $0 | 56,636 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 134,430 | — | $0 | 134,430 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,441 | — | $0 | 94,441 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-10-04 | 2023-10-05 | 372,671 | — | $0 | 372,671 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 41,065 | — | $0 | 41,065 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2022-10-07 | 2022-10-11 | 30,000 | $1.29 | $38.7K | 68,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-10-05 | 2022-10-07 | 74,878 | — | $0 | 74,878 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other | 2022-04-21 | 2022-04-22 | 27,982,529 | — | $0 | 55,816,786 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-03-23 | 2022-03-24 | 21,878 | — | $0 | 21,878 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-12-02 | 2021-12-02 | 18,000 | $1.40 | $25.2K | 38,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-10-05 | 2021-10-07 | 44,753 | — | $0 | 44,753 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-04-19 | 2021-04-20 | 10,000 | $1.82 | $18.2K | 20,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-03-24 | 2021-03-26 | 20,873 | — | $0 | 20,873 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-05 | 2020-10-05 | 151,721 | $0.51 | $77.4K | 151,721 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 296,352 | — | $0 | 296,352 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2020-09-17 | 2020-09-17 | 10,000 | $0.67 | $6.7K | 10,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 135,000 | — | $0 | 135,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 86,772 | $0.99 | $85.9K | 86,772 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 4,288,624 | $0.93 | $3.99M | 65,770,503 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-01-02 | 2019-01-03 | 4,288,624 | $0.93 | $3.99M | 61,481,879 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2018-12-31 | 2018-12-31 | 1,505 | — | $0 | 61,708 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2018-12-03 | 2018-12-06 | 4,288,624 | $0.93 | $3.99M | 57,193,255 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-11-07 | 2018-11-09 | 8,577,248 | $0.93 | $7.98M | 52,904,631 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2018-09-30 | 2018-10-02 | 1,648 | — | $0 | 60,383 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2018-09-30 | 2018-12-31 | 1,468 | — | $0 | 60,203 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2017-10-31 | 2017-11-02 | 25,000 | — | $0 | 25,000 | SEC↗ |